Efficacy and Safety of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD)
NCT06897839
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
366
Enrollment
INDUSTRY
Sponsor class
Conditions
Bronchopulmonary Dysplasia
Interventions
OTHER:
Air-sham
DRUG:
Zelpultide alfa
Sponsor
Airway Therapeutics, Inc.